Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a challenge study of GS-5806 in healthy adults experimentally infected with RSV-A
2012-002413-19Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing GS-5806 with Placebo (2 arms). Primary endpoint: Viral load area under the curve. Started Sep 2012; status: completed.
02
Drugs
presatovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2012-002413-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002413-19.